RxDoctor Payments Data

Kamal Patel, MD

Occupational Medicine · Lakeland, FLNPI 1750720025

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by SPR Therapeutics, Inc at 33.8% of the total. 2025 is the largest year on record at $17,004, more than ten times the $111 reported in 2019. Among occupational medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,976in general payments, 2019–2025

Across 328 payments — averaging $76.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$8K
  • AbbVie$8K
  • Boston Scientific$3K
  • Abbott$1K
  • Nalu Medical, Inc.$935
  • Saluda Medical Americas, Inc.$925
  • plus $3K from 24 others

What the payments were for

  • Consulting fees$12,31649%
  • Travel & lodging$3,14913%
  • Food & beverage$9,51138%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,976 in reported general payments places this provider in the 95th percentile of 34 occupational medicine providers in Florida.

See all occupational medicine providers in Florida

Medicare billing

Part B allowed, 2024
$406,653
Medicare patients
433
Services billed
6,138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BotoxOnabotulinumtoxina23$39,805
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,159$37,748
Xtampza ErOxycodone Myristate53$24,672
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen858$16,216
QuliptaAtogepant11$12,437
OxycontinOxycodone Hcl29$11,791
Pregabalin550$8,401
Oxycodone Hcl447$6,652
Gabapentin454$4,104
Morphine Sulfate ErMorphine Sulfate176$3,848
Buprenorphine13$3,773
Cyclobenzaprine Hcl274$3,325
Tramadol Hcl ErTramadol Hcl39$2,182
Naloxone Hcl31$1,945
Tramadol Hcl301$1,816

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieBotox, Qulipta$7,735$52,24334 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 34 occupational medicine providers in Florida.

Other occupational medicine in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →